Comparison between foam dressings impregnated with ionic silver and silver sulfadiazine cream 1% in treating deep burns.
Clinical Snapshot
PICO Framework
| P — Population | Adults aged 18-60 years with thermal burns affecting 10-30% body surface area with comparable percentage of deep dermal and full-thickness burns |
| I — Intervention | Foam dressings impregnated with ionic silver (AgF) |
| C — Comparator | 1% silver sulfadiazine cream (SSD) |
| O — Outcomes | Pain control, discomfort, wound infection, need for grafting, ease of application, length of stay, treatment cost |
Bottom Line
This small randomised trial (n=40) suggests ionic silver foam dressings may offer superior pain control and cost savings compared to silver sulfadiazine cream in deep burns. However, the study's validity is significantly limited by inadequate reporting of methodology, lack of statistical precision measures, and absence of blinding. While the 30.6% cost reduction is economically attractive, clinicians should interpret these preliminary findings cautiously. The comprehensive outcome assessment including patient comfort and economic factors is commendable, but larger, more rigorously reported trials are needed before changing established burn care protocols. The inability to blind participants and assessors to treatment allocation introduces substantial bias risk, particularly for subjective outcomes like pain and comfort.
Key Findings
P Value: Not reported
Effect Size: Not quantified in abstract
Primary Outcome: More effective pain control with ionic silver foam dressings
Nnt Or Sensitivity: Not calculable from available data
Confidence Interval: Not reported
Clinical Application
Ionic silver foam dressings readily available but may require staff training for optimal application Both treatments available through PBS for burn management; cost-effectiveness data relevant for hospital formulary decisions and clinical guidelines Adult burn patients with 10-30% TBSA deep burns in specialised burn units
Abstract
OBJECTIVE: The aim of this trial was to evaluate the effectiveness of foam dressings impregnated with ionic silver (AgF) compared to the traditional treatment of 1% silver sulfadiazine cream (SSD) in deep burns (deep dermal and full-thickness burns) and assess the cost-effectiveness ratio between the two treatments. METHOD: This was a randomised clinical trial of patients who were divided into two equal-sized treatment groups: Group 1-SSD or Group 2 - AgF. Inclusion criteria were patients aged between 18-60 years with burns of thermal origin affecting 10-30% of the body surface area, and with a comparable percentage of deep burns. The following outcomes were analysed: pain; discomfort; wound infection; need for new grafting; ease of dressing application; length of stay; and cost of treatment. RESULTS: A total of 40 patients took part (20 in each group). Regarding patients' experience of pain, data analysis revealed more effective pain control in patients treated with AgF. Additionally, the AgF dressing was considered safer, more comfortable and presented an average lower cost of 30.6% compared to the SSD. CONCLUSION: The findings of this trial showed that, compared to the SSD, the AgF dressings were more effective in treating deep burns, to prepare them for skin graft surgery.
References
- 1.Almeida, J. B., Coltro, P. S., Nunes, A. A., & Farina, J. A. (2024). Comparison between foam dressings impregnated with ionic silver and silver sulfadiazine cream 1% in treating deep burns. Journal of Wound Care. https://doi.org/10.12968/jowc.2024.0071
Related Research
Journal of the American College of Surgeons
Governance Framework for Safe and Ethical Implementation of Artificial Intelligence in Surgery: A Modified Delphi Consensus
13 June 2026
The Cochrane database of systematic reviews
Surgery for thumb (trapeziometacarpal joint) osteoarthritis
30 May 2026
Scientific reports
Uncertainty estimation and probabilistic skull shape reconstruction using bayesian neural networks
28 May 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service